MHCSZ-123 antibody offers strong antithrombotic effects by inhibition of collagen binding July 31, 2017
FDA grants fast track designation to caplacizumab for acquired thrombotic thrombocytopenic purpura July 26, 2017
Phase III results for emicizumab prophylaxis in patients with hemophilia A with inhibitors presented July 19, 2017
Julius-Maximilians-Universitaet Wuerzburg divulges polypeptides for thrombotic disorders July 18, 2017
RSS